277 related articles for article (PubMed ID: 20164601)
21. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
22. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
23. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease.
Liu ST; Howlett G; Barrow CJ
Biochemistry; 1999 Jul; 38(29):9373-8. PubMed ID: 10413512
[TBL] [Abstract][Full Text] [Related]
24. Nucleoside-5'-phosphorothioate analogues are biocompatible antioxidants dissolving efficiently amyloid beta-metal ion aggregates.
Amir A; Shmuel E; Zagalsky R; Sayer AH; Nadel Y; Fischer B
Dalton Trans; 2012 Jul; 41(28):8539-49. PubMed ID: 22652964
[TBL] [Abstract][Full Text] [Related]
25. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies.
Gaggelli E; Bernardi F; Molteni E; Pogni R; Valensin D; Valensin G; Remelli M; Luczkowski M; Kozlowski H
J Am Chem Soc; 2005 Jan; 127(3):996-1006. PubMed ID: 15656638
[TBL] [Abstract][Full Text] [Related]
26. Quenched hydrogen/deuterium exchange NMR characterization of amyloid-beta peptide aggregates formed in the presence of Cu2+ or Zn2+.
Olofsson A; Lindhagen-Persson M; Vestling M; Sauer-Eriksson AE; Ohman A
FEBS J; 2009 Aug; 276(15):4051-60. PubMed ID: 19549187
[TBL] [Abstract][Full Text] [Related]
27. Modeling of the Zn2+ binding in the 1-16 region of the amyloid beta peptide involved in Alzheimer's disease.
Furlan S; La Penna G
Phys Chem Chem Phys; 2009 Aug; 11(30):6468-81. PubMed ID: 19809679
[TBL] [Abstract][Full Text] [Related]
28. Metal binding affinities of Arabidopsis zinc and copper transporters: selectivities match the relative, but not the absolute, affinities of their amino-terminal domains.
Zimmermann M; Clarke O; Gulbis JM; Keizer DW; Jarvis RS; Cobbett CS; Hinds MG; Xiao Z; Wedd AG
Biochemistry; 2009 Dec; 48(49):11640-54. PubMed ID: 19883117
[TBL] [Abstract][Full Text] [Related]
29. Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
Lakatos A; Gyurcsik B; Nagy NV; Csendes Z; Wéber E; Fülöp L; Kiss T
Dalton Trans; 2012 Feb; 41(6):1713-26. PubMed ID: 22159144
[TBL] [Abstract][Full Text] [Related]
30. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T
Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357
[TBL] [Abstract][Full Text] [Related]
31. Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2008 Jul; 47(30):7796-806. PubMed ID: 18598056
[TBL] [Abstract][Full Text] [Related]
32. Zinc-mediated modulation of the configuration and activity of complexes between copper and amyloid-β peptides.
Liu L; Xia N
Biochem Biophys Res Commun; 2012 Jan; 417(1):153-6. PubMed ID: 22138653
[TBL] [Abstract][Full Text] [Related]
33. Investigations of the molecular mechanism of metal-induced Abeta (1-40) amyloidogenesis.
Lim KH; Kim YK; Chang YT
Biochemistry; 2007 Nov; 46(47):13523-32. PubMed ID: 17973493
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.
Mekmouche Y; Coppel Y; Hochgräfe K; Guilloreau L; Talmard C; Mazarguil H; Faller P
Chembiochem; 2005 Sep; 6(9):1663-71. PubMed ID: 16078307
[TBL] [Abstract][Full Text] [Related]
35. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
[TBL] [Abstract][Full Text] [Related]
36. Metal loading capacity of Abeta N-terminus: a combined potentiometric and spectroscopic study of zinc(II) complexes with Abeta(1-16), its short or mutated peptide fragments and its polyethylene glycol-ylated analogue.
Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
Inorg Chem; 2009 Nov; 48(21):10405-15. PubMed ID: 19780525
[TBL] [Abstract][Full Text] [Related]
37. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
38. Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.
Talmard C; Bouzan A; Faller P
Biochemistry; 2007 Nov; 46(47):13658-66. PubMed ID: 17983245
[TBL] [Abstract][Full Text] [Related]
39. Redox cycling of iron by Abeta42.
Khan A; Dobson JP; Exley C
Free Radic Biol Med; 2006 Feb; 40(4):557-69. PubMed ID: 16458186
[TBL] [Abstract][Full Text] [Related]
40. Nickel(II) and mixed metal complexes of amyloid-beta N-terminus.
Józsa E; Osz K; Kállay C; de Bona P; Damante CA; Pappalardo G; Rizzarelli E; Sóvágó I
Dalton Trans; 2010 Aug; 39(30):7046-53. PubMed ID: 20563338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
